Moreover, AKT was recently shown to inhibit GPX4 degradation through creatine kinase B-dependent phosphorylation, thereby mitigating ferroptosis in hepatocellular carcinoma cell lines [58]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.